You may currently be encountering challenges such as prolonged drug development cycles or difficulties in obtaining high-resolution structural data for complex protein targets. Our cryo-EM ribosome analysis service development helps you accelerate drug discovery by obtaining high-resolution structural information for the most complex targets. We use advanced cryo-EM technology to overcome the limitations of traditional methods.
The ribosome is a massive, multi-subunit macromolecular machine responsible for protein synthesis in all living organisms. Its complex and dynamic nature makes it an ideal, yet challenging, target for structural analysis. The use of cryo-EM has been a revolutionary breakthrough in this field, allowing scientists to bypass the need for crystallization and obtain high-resolution structures of the ribosome and its associated factors in various functional states. This technology provides a new frontier for understanding fundamental biological processes and for developing targeted antibacterial therapeutics that inhibit protein synthesis.
Fig.1 Cryo-EM structure of the 11-2F-bound PRMT5:MEP50 complex.1
Many antibiotics target bacterial ribosomes, but resistance is rising. cryo-EM structures of ribosome-antibiotic complexes reveal binding sites, allosteric effects, and resistance mutations. By analyzing pathogen-specific ribosomes, we identify selective inhibitors that spare human mitochondria, reducing toxicity.
Ribosomes vary widely across life, from extremophiles to organelles. cryo-EM uncovers structural innovations, such as simplified mitochondrial ribosomes or parasite-specific rRNA expansions in Plasmodium.
cryo-EM enables fragment-based screening by directly visualizing small molecules bound to ribosomal pockets. Our pipeline identifies lead compounds with novel scaffolds, prioritizing hits for medicinal chemistry.
cryo-EM validates engineered ribosomes with altered substrate specificities or drug resistance, ensuring functionality before deployment.
Our cryo-EM ribosome analysis delivers near-atomic resolution, enabling precise visualization of ribosomal subunits, active sites, and ligand interactions. This level of detail is critical for understanding translation mechanisms, antibiotic binding modes, and disease-related mutations. By leveraging cutting-edge microscopes and advanced image processing, we uncover structural features invisible to traditional techniques, empowering your research with unparalleled clarity.
We prioritize efficiency without sacrificing accuracy. Our streamlined workflow, from sample preparation to data processing, ensures results in weeks, not months. With dedicated experts optimizing every step, including automated particle picking and 3D reconstruction, we accelerate your project timeline while maintaining the highest quality standards. Ideal for time-sensitive drug discovery or structural biology milestones.
From native ribosomes to complex assemblies with ligands, mRNAs, or nascent chains, our platform accommodates diverse sample types. We specialize in challenging specimens, including low-abundance or heterogeneous complexes, using tailored cryo-plunging and grid optimization techniques. This versatility ensures your unique biological questions are addressed, whether studying bacterial, eukaryotic, or mitochondrial ribosomes.
Beyond raw data, we provide actionable insights. Our team of structural biologists and biochemists translates cryo-EM maps into mechanistic models, highlighting functionally relevant regions and potential drug targets. Custom reports include interactive 3D visualizations, validation metrics, and comparative analyses with existing structures, enabling you to make informed decisions swiftly.
A: cryo-EM is particularly advantageous for large, dynamic, or difficult-to-crystallize complexes like the ribosome. It allows us to visualize the structure in a near-native state without the need for extensive and often unsuccessful crystallization trials, saving you significant time and resources.
A: One of the key benefits of cryo-EM single-particle analysis is its low sample volume requirement. We can often achieve high-quality results with as little as a few hundred micrograms of purified material, which is a major advantage for projects with limited sample availability.
A: Yes, our cryo-EM Ribosome Analysis Service is specifically designed for this. We can co-incubate your small molecule with the ribosome to determine the precise binding location and mechanism at an atomic level, providing the insights you need for lead optimization.
A: We follow a rigorous, multi-step workflow including negative staining screening, high-resolution data collection with state-of-the-art instruments, and advanced computational refinement. We also provide all raw data files and a detailed report, ensuring full transparency and reproducibility.
A: Our comprehensive approach combines advanced technology with deep biological expertise. Unlike single-service providers, we can recommend and execute the most suitable technique for your specific project, whether it's cryo-EM, X-ray, or NMR, providing a truly holistic solution.
Creative Biolabs provides a powerful, integrated platform for solving the most challenging structural biology problems. Our cryo-EM ribosome analysis service is just one example of how we combine cutting-edge technology with unparalleled expertise to accelerate your research and guide your project toward success. From sample to final structure, we are committed to being your trusted partner in drug discovery. To discuss your project in detail and learn how our cryo-EM expertise can benefit you, please contact our team.
Reference
(USA)
(UK)
(Germany)